A study that included nearly 2,500 HIV-negative men and transgender women who have sex with men has shown that a daily dose of Truvada, a pill containing the AIDS drugs emtricitabine and tenofovir, “can reduce risk of contracting [HIV] by an average of 44% â€“ and by more than 70% if the subjects” follow the regimen closely, Los Angeles Times reports (Maugh, 11/23).
UNAIDS Report Finds New HIV Infections Dropped By 20% Over 10 Years, Deaths From AIDS-Related Illness Dropped By 20% Over 5 Years
The number of new HIV infections “has dropped by about one-fifth over the past decade but millions of people are still missing out on major progress in prevention and treatment,” according to the annual UNAIDS report released Tuesday, Agence France-Presse reports. “In 2009, 2.6 million people contracted the HIV virus that causes AIDS, a decline of 19 percent over the 3.1 million recorded in” 1999 the report found, according to the news service (11/23).
“Pope Benedict XVI says in a new book that condoms can be justified for male prostitutes seeking to stop the spread of HIV, a stunning comment for a church criticized for its opposition to condoms and for a pontiff who has blamed them for making the AIDS crisis worse,” the Associated Press/Washington Post reports. The pope’s comments were made public on Saturday, when a Vatican newspaper ran excerpts from Benedict’s book-length interview with German Journalist Peter Seewald for “Light of the World: The Pope, the Church and the Signs of the Times,” due out Tuesday, the news service writes (D’Emilio/Winfield, 11/21).
“Despite the gains associated with antiretroviral treatments (ART) over the last decade, HIV/AIDS remains the leading cause of death among young and middle-aged adults in the Caribbean, warns a new U.N. report” that was released during the 10th Annual General Meeting of the Pan Caribbean Partnership Against HIV and AIDS (PANCAP) that concluded on Tuesday, Inter Press Service reports (Richards, 11/3).
ASTMH Meeting Blog: The American Society of Tropical Medicine and Hygiene’s (ASTMH) “Annual Meeting Blog” has a number of posts from this week’s gathering, including: “The ethics of overseas clinical research”; an interview with John Cook, former ASTMH president; American attention to dengue fever; a profile of Michele Barry, senior…
Progress, Challenges In Curbing Neglected Tropical Diseases: “The effect of 30 years of neglect for these diseases in research and development of new diagnostics and drugs, and, crucially, in investing in training and education in vector-borne diseases, is evident. Most current drugs for neglected tropical diseases are old, and the…
“A record 1.2 million people in low- and middle-income countries started antiretroviral therapy for HIV/AIDS in 2009” â€“ a 30 percent increase from the previous year and a 13-fold increase in six years, according to a joint report released Tuesday by the WHO, UNICEF and UNAIDS, Reuters reports. In total, the report found that 5.25 million people received antiretroviral therapy (ART) in 2009, three-quarters of them living in Africa (Migiro, 9/28).
“Doctors and AIDS activists on Friday urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS,” the Associated Press reports.
Also In Global Health News: Kenya Votes On Constitution; Global Wheat Prices Soar; HIV And TB In China; Female Condoms In India; Malaria Centers Receive Funding
As Kenya Votes For Constitution, Abortion And HIV Rights Issues Remain Kenyans “voted peacefully” Wednesday on a constitution that most were “expected to vote in favour” of, according to surveys, Reuters reports (8/4). Kenyan officials have supported the constitution but, VOA News reports, “issues of abortion, land, and Islamic courts”…
The New York Times examines a set of questions raised by news out of the International AIDS Conference-AIDS 2010 last week that a microbicide gel containing the antiretroviral (ARV) tenofovir used by women before and after sex helped reduce their risk of HIV infection by 39 percent.